SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-307204
Filing Date
2011-11-10
Accepted
2011-11-10 17:15:41
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d237086d10q.htm 10-Q 903848
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d237086dex311.htm EX-31.1 5442
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER d237086dex312.htm EX-31.2 5570
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d237086dex321.htm EX-32.1 4480
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER d237086dex322.htm EX-32.2 4446
  Complete submission text file 0001193125-11-307204.txt   2336185

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zgnx-20110930.xml EX-101.INS 278552
7 XBRL TAXONOMY EXTENSION SCHEMA zgnx-20110930.xsd EX-101.SCH 10235
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zgnx-20110930_cal.xml EX-101.CAL 33704
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zgnx-20110930_lab.xml EX-101.LAB 101644
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zgnx-20110930_pre.xml EX-101.PRE 62567
Mailing Address 12671 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12671 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 (858) 259-1165
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34962 | Film No.: 111196366
SIC: 2834 Pharmaceutical Preparations